What we're reading, November 10, 2016: right-to-die supporters start eyeing the next states; healthcare winners and losers after the election; and women are promoting birth control access before the Affordable Care Act is dismantled.
On Election Day, Colorado approved an initiative that would provide access to life-ending medications for terminally ill patients. According to Kaiser Health News, supporters of the initiative are now turning their gaze on other parts of the country. The District of Columbia may be the next to approve such legislation, there is pending legislation in New Jersey, and New York may reintroduce a right-to-die law in January. Supporters are also prepared to campaign in Maryland, Minnesota, Hawaii, New Mexico, and Massachusetts.
There is a lot of uncertainty in the healthcare industry following Donald Trump’s election. Drug makers’ stocks were up, but hospital stocks were down the day after Election Day, and the Affordable Care Act (ACA) seems poised to be gutted. The Washington Post outlined the winners and losers in the aftermath of the election and highlighted the confusion among companies as they try to understand what a repeal of President Barack Obama’s healthcare law will actually mean for business.
Women are taking to social media to encourage each other to get to the gynecologist and enjoy access to contraceptives as guaranteed under Obamacare while they still can. Women are concerned that birth control costs will increase and access to Planned Parenthood limited under the next administration, reported USA TODAY. In particular, the intrauterine device is being promoted because it can last between 3 and 12 years, is heavily subsidized or free under the ACA, and once it is implanted the only additional costs or maintenance come if there are complications or the device is removed.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More